P300 Health related quality of life results through week 22 from the CERTIFI study, a multicenter, randomized, double-blind, placebo-controlled Phase2b study of ustekinumab in patients with moderately to severely active Crohn's disease

Details

Language :

English

ISSN :

18739946

Volume :

6

Database :

Academic Search Index

Journal :

Journal of Crohn's & Colitis

Publication Type :

Academic Journal

Accession number :

71513144

Full Text :

https://doi.org/10.1016/S1873-9946(12)60320-1